0 items

in your cart
$0.00

Prescription Drug Search

Strengths available for Lubiprostone :

Lubiprostone 8mcg
Lubiprostone 24mcg

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Lubiprostone:

  • Algeria
  • Azerbaijan
  • Bahrain
  • Barbados
  • Cayman Islands
  • China
  • Ecuador
  • Egypt
  • El Salvador
  • Estonia
  • European Union
  • Gibraltar
  • Guatemala
  • Honduras
  • Hungary
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Jamaica
  • Jordan
  • Kuwait
  • Lebanon
  • Mauritius
  • Netherlands
  • New Zealand
  • Nicaragua
  • Philippines
  • Poland
  • Romania
  • Saudi Arabia
  • Seychelles
  • Singapore
  • Thailand
  • Tunisia
  • United Arab Emirates
  • United Kingdom, UK
  • United States, US
  • Uzbekistan
View All Countries

Latest news releases on Lubiprostone:

Sucampo Presents Detailed Results of Positive Phase 3 Trial of Lubiprostone in Opioid-Induced Bowel Dysfunction (OBD) - Yahoo Finance

Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP - News) today announced the presentation of positive data from a Phase 3 clinical trial of lubiprostone for the treatment of opioid-induced bowel dysfunction (OBD), at Digestive Disease Week 2012, held ...

Sucampo Presents New Phase III Data from Opioid-Induced Bowel Dysfunction Study - Genetic Engineering News

Sucampo Pharmaceuticals presented new data from a third Phase III trial evaluating lubiprostone in the treatment of opioid-induced bowel dysfunction (OBD) in patients with chronic noncancer pain. Initial results from the study were reported in April.

Sucampo Pharmaceuticals, Inc. : Sucampo Presents Detailed Results of Positive Phase 3 Trial of Lubiprostone in Opioid-Induced Bowel Dysfunction (OBD) - 4-traders (press release)

Data Presented in Clinical Practice Distinguished Abstract Plenary Session at Digestive Disease Week 2012 Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced the presentation of positive data from a Phase 3 clinical trial of lubiprostone for the ...

Sucampo Presents Data for AMITIZA® in the Treatment of Moderate to Very Severe Irritable Bowel Syndrome with Constipation (IBS-C) - Yahoo Finance

Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP - News) today announced the presentation of pooled data from post-hoc analyses of the two pivotal Phase 3 studies of AMITIZA ® (lubiprostone) for the treatment of irritable bowel syndrome with ...

Sucampo Presents Data for AMITIZA(R) in the Treatment of Moderate to ...  - CNBC

BETHESDA, Md., May 20, 2012 (BUSINESS WIRE) -- Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced the presentation of pooled data from post-hoc analyses of the two pivotal Phase 3 studies of AMITIZA(R) (lubiprostone) for the treatment of ...

Sucampo Presents Data for AMITIZA(R) in the Treatment of Moderate to Very Severe Irritable Bowel Syndrome with Constipation (IBS-C) - comcast.net

BETHESDA, Md., May 20, 2012 (BUSINESS WIRE) -- Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced the presentation of pooled data from post-hoc analyses of the two pivotal Phase 3 studies of AMITIZA(R) (lubiprostone) for the treatment of ...

Gaithersburg drug-maker signs deal for European market - Maryland Community Newspapers Online

Sucampo previously reported that lubiprostone met its primary endpoint and was found to be safe and well-tolerated, but it disclosed new results at the conference. For example, patients taking lubiprostone had an initial spontaneous bowel ...

Drugs in the Pipeline - Monthly Prescribing Reference

Sucampo announced positive data from a Phase 3 clinical trial of lubiprostone for the treatment of opioid-induced bowel dysfunction (OBD). New Phase 3 study findings show that subcutaneous induction regimens of Simponi (golimumab; Janssen Biotech ...

Customer Service
1-866-799-3435 - Use Discount Code 7500 | Contact Form
Copyright © 2012 ExpressMedsCanada.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK